准过度表达的表面蛋白:一种新的策略来管理反抗性的三阴性乳腺癌
Alan Raj1, Sarath Chandran C2, Kamal Dua3
1Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Udupi, Karnataka state, India, 576104.
European journal of pharmacology
|August 18, 2024
概括
用纳米粒子向三阴性乳腺癌 (TNBC) 上的特定表面蛋白质提供了一个有前途的治疗策略. 这种方法通过利用连接物来向像EGFR这样的过度表达的蛋白质来提高这种侵袭性癌症的治疗效率.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 分子生物学分子生物学
背景情况:
- 三重阴性乳腺癌 (TNBC) 具有攻击性,缺乏雌激素,孕激素和HER2受体,限制了治疗选择.
- 目前的TNBC治疗依赖于化疗和手术,由于耐药性,成功程度有限.
- 基于纳米粒子的主动向显示出比被动方法更大的潜力,用于TNBC管理.
研究的目的:
- 审查TNBC细胞上过度表达的表面蛋白质,包括αVβ3整体蛋白,ICAM-1,GLUT5,MUC-1和EGFR.
- 讨论针对TNBC的向纳米配方在临床前开发中的挑战.
- 探索连接体结合纳米颗粒用于TNBC的向治疗.
主要方法:
- 审查免疫组织化学分析,确定TNBC表面蛋白质表达.
- 分析纳米粒子内部化和临床前翻译方面的挑战.
- 讨论使用体,抗体和糖分子的基于联体的向策略.
主要成果:
- 细胞过度表达特定的表面蛋白质:αVβ3整体蛋白,ICAM-1,GLUT5,MUC-1和EGFR.
- 干可以向这些过度表达的蛋白质,从而有可能改善治疗的遵守性.
- 目标纳米颗粒的成功翻译面临临临床前和内部化挑战.
结论:
- 向TNBC表面蛋白与配体结合纳米颗粒是改善治疗结果的可行策略.
- 克服临床前和转化挑战对于向纳米配方的临床成功至关重要.
- 对联体受体相互作用和纳米粒子传递系统的进一步研究是有必要的.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


